Amit G Singal1, Sarah Reddy2, Himani Radadiya Aka Patel3, Deyaun Villarreal3, Aisha Khan4, Yan Liu4, Vanessa Cerda3, Nicole E Rich2, Caitlin C Murphy3, Jasmin A Tiro3, Jennifer R Kramer5, Ruben Hernaez5. 1. Department of Internal Medicine, UT Southwestern Medical Center and Parkland Health Hospital System, Dallas, Texas. Electronic address: amit.singal@utsouthwestern.edu. 2. Department of Internal Medicine, UT Southwestern Medical Center and Parkland Health Hospital System, Dallas, Texas. 3. Department of Population Sciences, UT Southwestern Medical Center and Parkland Health Hospital System, Dallas, Texas. 4. Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas. 5. Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas; Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas.
Abstract
BACKGROUND: The effectiveness of hepatocellular carcinoma (HCC) surveillance is mitigated by underuse in clinical practice, highlighting a need for interventions. We evaluated the effectiveness of mailed HCC surveillance outreach to promote HCC surveillance in patients with cirrhosis. METHODS: We conducted a multicenter pragmatic randomized clinical trial comparing mailed outreach for surveillance ultrasound (n = 1436) and usual care with visit-based surveillance (n = 1436) among patients with cirrhosis at 3 health systems (tertiary care referral center, safety net health system, and Veterans Affairs medical center) from April 2018 to December 2019. The primary outcome of this interim analysis was guideline concordant semiannual HCC surveillance over a 12-month period and a secondary outcome was proportion time covered by surveillance. All patients were included in intention-to-screen analyses. RESULTS: Compared with usual care, the outreach arm had significantly higher semiannual surveillance (35.1% vs 21.9%) and lower no-surveillance (29.8% vs 43.5%) (P < .001), resulting in significant increases in the proportion of time covered by surveillance (41.3% vs 31.0%; P < .001). The intervention increased HCC surveillance across most predefined subgroups; however, there were site-level differences in the intervention effect, with significant increases in semiannual surveillance at the Veterans Affairs and safety net health systems but not at the tertiary care referral center. CONCLUSIONS: Mailed outreach significantly increased semiannual HCC surveillance vs usual care in patients with cirrhosis, with a consistent intervention effect across most examined subgroups. Continued follow-up is ongoing to determine if these increases in surveillance translate into improved downstream outcomes includi.ng early HCC detection and curative treatment receipt. (ClinicalTrials.gov, Numbers: NCT02582918 and NCT03756051).
BACKGROUND: The effectiveness of hepatocellular carcinoma (HCC) surveillance is mitigated by underuse in clinical practice, highlighting a need for interventions. We evaluated the effectiveness of mailed HCC surveillance outreach to promote HCC surveillance in patients with cirrhosis. METHODS: We conducted a multicenter pragmatic randomized clinical trial comparing mailed outreach for surveillance ultrasound (n = 1436) and usual care with visit-based surveillance (n = 1436) among patients with cirrhosis at 3 health systems (tertiary care referral center, safety net health system, and Veterans Affairs medical center) from April 2018 to December 2019. The primary outcome of this interim analysis was guideline concordant semiannual HCC surveillance over a 12-month period and a secondary outcome was proportion time covered by surveillance. All patients were included in intention-to-screen analyses. RESULTS: Compared with usual care, the outreach arm had significantly higher semiannual surveillance (35.1% vs 21.9%) and lower no-surveillance (29.8% vs 43.5%) (P < .001), resulting in significant increases in the proportion of time covered by surveillance (41.3% vs 31.0%; P < .001). The intervention increased HCC surveillance across most predefined subgroups; however, there were site-level differences in the intervention effect, with significant increases in semiannual surveillance at the Veterans Affairs and safety net health systems but not at the tertiary care referral center. CONCLUSIONS: Mailed outreach significantly increased semiannual HCC surveillance vs usual care in patients with cirrhosis, with a consistent intervention effect across most examined subgroups. Continued follow-up is ongoing to determine if these increases in surveillance translate into improved downstream outcomes includi.ng early HCC detection and curative treatment receipt. (ClinicalTrials.gov, Numbers: NCT02582918 and NCT03756051).
Authors: Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach Journal: Hepatology Date: 2018-08 Impact factor: 17.425
Authors: Caitlin C Murphy; Ethan A Halm; Celette Sugg Skinner; Bijal A Balasubramanian; Amit G Singal Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-05-26 Impact factor: 4.254
Authors: Jennifer S Haas; Brian L Sprague; Carrie N Klabunde; Anna N A Tosteson; Jane S Chen; Asaf Bitton; Elisabeth F Beaber; Tracy Onega; Jane J Kim; Charles D MacLean; Kimberly Harris; Phillip Yamartino; Kathleen Howe; Loretta Pearson; Sarah Feldman; Phyllis Brawarsky; Marilyn M Schapira Journal: J Gen Intern Med Date: 2016-01 Impact factor: 5.128
Authors: Debra T Choi; Hye-Chung Kum; Sulki Park; Robert L Ohsfeldt; Yu Shen; Neehar D Parikh; Amit G Singal Journal: Clin Gastroenterol Hepatol Date: 2018-10-26 Impact factor: 11.382
Authors: Mahendra S Nehra; Ying Ma; Christopher Clark; Ruben Amarasingham; Don C Rockey; Amit G Singal Journal: J Clin Gastroenterol Date: 2013 May-Jun Impact factor: 3.062
Authors: Amit G Singal; Adam C Yopp; Samir Gupta; Celette Sugg Skinner; Ethan A Halm; Eucharia Okolo; Mahendra Nehra; William M Lee; Jorge A Marrero; Jasmin A Tiro Journal: Cancer Prev Res (Phila) Date: 2012-07-30
Authors: Christian B van der Pol; Christopher S Lim; Claude B Sirlin; Trevor A McGrath; Jean-Paul Salameh; Mustafa R Bashir; An Tang; Amit G Singal; Andreu F Costa; Kathryn Fowler; Matthew D F McInnes Journal: Gastroenterology Date: 2018-11-13 Impact factor: 22.682
Authors: Jennifer D Allen; Shirley Morrison Bluethmann; Margaret Sheets; Kelly Morrison Opdyke; Kathryn Gates-Ferris; Marc Hurlbert; Elizabeth Harden Journal: BMC Public Health Date: 2013-12-12 Impact factor: 3.295